Lexicon Pharmaceuticals | Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Abbott USD 6.54B 625M 2025-12
Acadia Pharmaceuticals USD 256.99M 13.15M 2025-09
Agios Pharmaceuticals USD 11.2M 448K 2025-09
Akebia Therapeutics USD 49.21M 13.25M 2025-03
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Coherus Biosciences USD 4.95M 15.34M 2025-03
Eli Lilly USD 14.59B 1.48B 2025-09
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Illumina USD 759M 26M 2025-12
Insmed USD 111.44M 33.36M 2025-09
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
J&J USD 16.6B 118M 2025-12
Lexicon Pharmaceuticals USD -16.16M 2.89M 2024-06
MacroGenics USD 61.25M 88.71M 2025-09
MannKind USD 2.1M 216K 2025-09
Merck USD 13.42B 431M 2025-09
Moderna USD 809M 791M 2025-09
Novartis USD 10.82B 695M 2025-09
PTC Therapeutics USD 187.69M 24.3M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Ultragenyx Pharmaceutical USD 131.94M 11.55M 2025-09
United Therapeutics USD 602.1M 108.9M 2025-09
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12


Lexicon Pharmaceuticals Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.